South African Medical News

Back to Home Page

Print using browser
Esmocard 100 mg/10 ml solution for infusion, esmolol hydrochloride (Equity Pharmaceuticals)

equitypharmaceuticalslogo3






Dear Healthcare Professional

Equity Pharmaceuticals is proud to announce the registration and availability of Esmocard® 100 mg/10 ml solution for infusion in South Africa.

Esmocard® 100 mg/10 ml (Solution for infusion) – each vial contains as active ingredient 10 mg/ml esmolol hydrochloride i.e.: 100 mg/10 ml single dose vial.

For orders, please email: orders@equitypharma.co.za

If you have any further queries, please contact your Equity Pharmaceuticals representative.

esmocardpack

  • This is a drug - read the leaflet carefully before use 
  • Ask your doctor or pharmacist for further information.
Equity Pharmaceuticals thank you for your continued support.

FOR FULL PRESCRIBING INFORMATION REFER TO THE PACKAGE INSERT APPROVED BY THE MEDICINES REGULATORY AUTHORITY.

S3 ESMOCARD 100 mg/10 ml: Reg No: 45/5.2/0806. Each single dose vial contains 10 mg/ml esmolol hydrochloride, i.e. 100 mg/10 ml single dose vial. Each box contains 5 vials.

Equity Pharmaceuticals, 100 Sovereign Drive, Route 21, Corporate Park, Nellmapius Drive, Irene, 0157


You need to be logged in to see more details. Register Now!


Click here to visit the Equity Pharmaceuticals website.....
Contact: Tracey Clark, Business Unit Manager: Neurology/ Hospital Division
Telephone: +27 (0) 12 345 1747
E-mail: tracey@equitypharma.co.za
Date: Tuesday, March 19, 2019